首页> 外文OA文献 >Characterization of aldehyde dehydrogenase 1 high ovarian cancer cells: Towards targeted stem cell therapy

【2h】

Characterization of aldehyde dehydrogenase 1 high ovarian cancer cells: Towards targeted stem cell therapy

机译：醛脱氢酶1高卵巢癌细胞的表征：朝向靶向干细胞疗法

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Allison C. Sharrow; Brandy Perkins; Michael I. Collector; Wayne Yu; Brian W. Simons; Richard J. Jones;
展开▼
作者单位

展开▼
年度 2016
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Characterization of aldehyde dehydrogenase 1 high ovarian cancer cells: Towards targeted stem cell therapy [J] . Sharrow Allison C., Perkins Brandy, Collector Michael I., Gynecologic Oncology: An International Journal . 2016,第2期

机译：醛脱氢酶1高卵巢癌细胞的表征：靶向干细胞疗法
2. Exploring the clonal evolution of CD133/aldehyde-dehydrogenase-1 (ALDH1)-positive cancer stem-like cells from primary to recurrent high-grade serous ovarian cancer (HGSOC). A study of the Ovarian Cancer Therapy-Innovative Models Prolong Survival (OCTIPS) Consortium [J] . Ruscito Ilary, Castillo-Tong Dan Cacsire, Vergote Ignace, European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2017,第期

机译：探索CD133 /醛 - 脱氢酶-1（ALDH1） - 阳性癌症状细胞的克隆演化从初发于经常性高级浆液癌（HGSOC）。卵巢癌治疗 - 创新模型的研究延长生存（八层）财团
3. Targeting aldehyde dehydrogenase cancer stem cells in ovarian cancer. [J] . Landen CN Jr, Goodman B, Katre AA, Molecular cancer therapeutics . 2010,第12期

机译：靶向醛脱氢酶癌症干细胞的卵巢癌。
4. AAV GENE THERAPY FOR ALCOHOLISM: INHIBITION OF MITOCHONDRIAL ALDEHYDE DEHYDROGENASE ENZYME EXPRESSION IN HEPATOMA CELLS. [C] . Anamaria C. Sanchez, Chengwen Li, Jude Samulski, Biochemical and molecular engineering XX: the next generation of biochemical engineering: from nanoscale to industrial scale . 2017

机译：酒精中毒的AAV基因治疗：抑制肝癌细胞线粒体醛脱氢酶的酶表达。
5. Receptor tyrosine kinase-like orphan receptor-1 (ROR1) expression in breast cancer stem cells can be targeted for anti-cancer-stem-cell therapy [D] . Liu, Grace. 2015

机译：乳腺癌干细胞中受体酪氨酸激酶样孤儿受体1（ROR1）的表达可用于抗癌干细胞治疗
6. Characterization of Aldehyde Dehydrogenase 1 High Ovarian Cancer Cells: Towards Targeted Stem Cell Therapy [O] . Allison C. Sharrow, Brandy Perkins, Michael I. Collector, -1

机译：醛脱氢酶1高卵巢癌细胞的表征：定向干细胞疗法。
7. Exploring the clonal evolution of CD133/aldehyde-dehydrogenase-1 (ALDH1)-positive cancer stem-like cells from primary to recurrent high-grade serous ovarian cancer (HGSOC). A study of the Ovarian Cancer Therapy-Innovative Models Prolong Survival (OCTIPS) Consortium. [O] . Ruscito, I, Cacsire Castillo-Tong, D, Vergote, I, 2017

机译：探索CD133 /醛脱氢酶-1（ALDH1）阳性癌症干样细胞从原发性到复发性高级别浆液性卵巢癌（HGSOC）的克隆进化。卵巢癌治疗创新模型延长生存期（OCTIPS）联盟的研究。

Characterization of aldehyde dehydrogenase 1 high ovarian cancer cells: Towards targeted stem cell therapy

著录项

引文网络

相似文献

相关主题

期刊订阅